Validity of endocan as a biomarker in systemic sclerosis: relation to pathogenesis and disease activity

Validity of endocan as a biomarker in systemic sclerosis: relation to pathogenesis and disease activity

Abstract Background Systemic sclerosis (SSc), an autoimmune disease, has endothelial dysfunction and tissue fibrosis. The lack of its specific activity markers urges the research. Endocan is an immunomodulatory protein associated with endothelial dysfunction. We aimed to measure of the endocan level...

Full description

Bibliographic Details
Main Authors: Marwa Yahia Mahgoub, Ali Ibrahim Fouda, Ahmed Yousef Elshambaky, Walaa Bayoumie Elgazzar, Sara Abdellatif Shalaby
Format: Article
Language:English
Published: SpringerOpen 2020-11-01
Series:Egyptian Rheumatology and Rehabilitation
Subjects:
Endocan
Systemic sclerosis
Rheumatoid arthritis
Behcet’s disease
Online Access:http://link.springer.com/article/10.1186/s43166-020-00025-2

Internet

http://link.springer.com/article/10.1186/s43166-020-00025-2

Similar Items